Flagship Ventures Fund IV General Partner LLC Insider Trading $MCRB Seres Therapeutics, Inc.
Get free email notifications about insider trading for Flagship Ventures Fund IV General Partner LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Flagship Ventures Fund IV General Partner LLC. Flagship Ventures Fund IV General Partner LLC is 10% Owner in Seres Therapeutics, Inc. ($MCRB) and 10% Owner in Axcella Health Inc. ($AXLA) and Director in Moderna, Inc. ($MRNA) and 10% Owner in Evelo Biosciences, Inc. ($EVLO) and 10% Owner in Rubius Therapeutics, Inc. ($RUBY) and Director in Rubius Therapeutics, Inc. ($RUBY) and 10% Owner in Kaleido Biosciences, Inc. ($KLDO) and Director in Kaleido Biosciences, Inc. ($KLDO) and 10% Owner in TransMedics Group, Inc. ($TMDX).
Flagship Ventures Fund IV General Partner LLC in Seres Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Flagship Ventures Fund IV General Partner LLC: 10% Owner
Holdings: 4,434,600 shares
Current Value: $42,128,700
Latest Transaction: Nov 25 2020
$MCRB Market Capitalization: $374.90M
$MCRB Previous Close: $9.50
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Flagship Ventures Fund IV General Partner LLC in Seres Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AXLA, EVLO, KLDO, MRNA, RUBY, MCRB, TMDX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 25 2020 | MCRB | Seres Therapeutics ... | Flagship Ventures Fund IV Gene ... | 10% Owner | Sell | J | 0.00 | 43,154 | 0 | 0 | 43.2 K to 0 (-100.00 %) |
| Nov 25 2020 | MCRB | Seres Therapeutics ... | Flagship Ventures Fund IV Gene ... | 10% Owner | Sell | J | 0.00 | 1,481,481 | 0 | 2,962,963 | 4.4 M to 3 M (-33.33 %) |
| Nov 25 2020 | MCRB | Seres Therapeutics ... | Flagship Ventures Fund IV Gene ... | 10% Owner | Sell | J | 0.00 | 1,186,310 | 0 | 3,258,134 | 4.4 M to 3.3 M (-26.69 %) |
| Nov 25 2020 | MCRB | Seres Therapeutics ... | Flagship Ventures Fund IV Gene ... | 10% Owner | Sell | J | 0.00 | 966,234 | 0 | 0 | 966.2 K to 0 (-100.00 %) |
| Nov 25 2020 | MCRB | Seres Therapeutics ... | Flagship Ventures Fund IV Gene ... | 10% Owner | Sell | J | 0.00 | 642,180 | 0 | 1,283,282 | 1.9 M to 1.3 M (-33.35 %) |
| Nov 25 2020 | MCRB | Seres Therapeutics ... | Flagship Ventures Fund IV Gene ... | 10% Owner | Sell | J | 0.00 | 3,587,820 | 0 | 4,434,600 | 8 M to 4.4 M (-44.72 %) |
Page: 1